Brandon Allgood's guest appearances

Brandon Allgood

The Alldus Podcast - AI in Action

Chris Hutchins

John Collins

Kevin Johnson

Adam Wenchel

Kraft Heinz

Sean McDermott

Levi Strauss

Jason King

Jenny Zhang

Martin Miller

Gary Beasley

Rich Jones

Nick Adams

Charles Taylor

Brad Taylor

OwlTail

Today's guest is Brandon Allgood, Senior Vice President of Data Science &amp; AI at Valo Health in San Francisco. Founded in 2019, Valo are using cloud computing as well as longitudinal and human data to create an entirely new drug discovery and development process. With 15 years of experience in large scale cloud and distributed computing, AI and mathematical modeling, Brandon currently manages the development and application of Valo's AI platform and is responsible for Valo's overall technological vision. Valo’s Opal Computational PlatformTM, a cloud generation, fully-integrated, componentized, end-to-end drug development platform, drug development is positioned to be transformed into a far more efficient process with life-changing treatments created in potentially half the time at far less cost and with far fewer failures. The Opal Platform makes it possible for scientists to review human data to discover previously unsuspected associations between genetic markers and disease and design and discover proprietary new molecules. In the episode, Brandon will discuss: Interesting roles he’s held throughout his career, Challenges they are solving at Valo Health, Their impact in drug discovery and clinical trials, Future innovations in pharma that excite him, Tackling bias and unfairness in AI, and  How to build a successful data science team

Today's guest is Brandon Allgood, Senior Vice President of Data Science &amp; AI at <a href="https://www.valohealth.com/" rel="noopener nofollow" target="_blank">Valo</a><a href="https://www.valohealth.com/" rel="noopener nofollow" target="_blank"> Health</a> in San Francisco. Founded in 2019, Valo are using cloud computing as well as longitudinal and human data to create an entirely new drug discovery and development process. With 15 years of experience in large scale cloud and distributed computing, AI and mathematical modeling, Brandon currently manages the development and application of Valo's AI platform and is responsible for Valo's overall technological vision. Valo’s Opal Computational PlatformTM, a cloud generation, fully-integrated, componentized, end-to-end drug development platform, drug development is positioned to be transformed into a far more efficient process with life-changing treatments created in potentially half the time at far less cost and with far fewer failures. The Opal Platform makes it possible for scientists to review human data to discover previously unsuspected associations between genetic markers and disease and design and discover proprietary new molecules. In the episode, Brandon will discuss: Interesting roles he’s held throughout his career, Challenges they are solving at Valo Health, Their impact in drug discovery and clinical trials, Future innovations in pharma that excite him, Tackling bias and unfairness in AI, and  How to build a successful data science team

 E184 Brandon Allgood, SVP of Data Science & AI at Valo Health